Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-03-09 @ 5:48 AM
Study NCT ID:
NCT02109627
Status:
TERMINATED
Last Update Posted:
2020-03-24
First Post:
2014-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML
Sponsor:
C. Babis Andreadis
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
139510
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None